Project Grant RF1AG087210
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $2.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, DE 19713, USA
Similar Awards
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $302,960 to Harvard T.H. Chan School of Public Health to conduct research on identifying individuals who would benefit most from intensive blood pressure control for preventing cognitive decline and dementia, as well as those at risk of serious adverse events. The research will utilize advanced statistical methods and pooled data from multiple large-scale randomized trials to detect...
- This $5,789,766 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will examine the effects of intensive blood pressure control on mild cognitive impairment, dementia, and plasma biomarker trajectories by Alzheimer's disease pathology. The study aims to elucidate neuroprotective effects in the racially and ethnically diverse SPRINT trial cohort. The University of Utah is the primary awardee and will conduct this research over a period of approximately 5...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) is for the research project "Impact of Hypertension and Aging on Postoperative Delirium". The $715,801 grant, awarded on June 1, 2025, supports Duke University's research to elucidate the contributions of endothelial cells and perivascular macrophages to surgery-induced neuroinflammation, blood-brain barrier disruption, and delirium-like behavior in aging and hypertension. The overarching...
- This federal Project Grant award of $2,709,669 from the National Institute on Aging (Aging Research, CFDA 93.866) aims to provide rigorous evidence on the outcomes of home-based versus facility-based care for older patients with Alzheimer's disease and related dementias (AD/ADRD). The research strategy will leverage differences in the influence of physical therapists on discharge destination as a "randomizing device" to compare outcomes across almost 100 VA hospitals. This novel...
- This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
- This federal Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $443,365.00 to the University of Maryland, College Park to conduct research on the brain renin-angiotensin system and its relationship to Alzheimer's disease. The research, which runs from August 1, 2024 to July 31, 2026, will focus on: Measuring brain angiotensin peptides and peptidases in a genetically diverse Alzheimer's disease mouse model to understand the...
- This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $131,813 Project Grant to the Trustees of Boston University (Boston University Medical Campus) on May 1, 2025. The grant aims to evaluate the effects of poverty alleviation policies, such as the Supplemental Nutrition Assistance Program (SNAP), on the risk and disparities of Alzheimer's disease and related dementias (AD/ADRD). The research will leverage data from the Health and...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $344,164 project grant to Northwestern University to develop "M4: Modules on Advanced Methodology When Modeling Multinational Data." The primary objectives are to: 1) create a training program in large-scale data analysis for the next generation of researchers, 2) instruct trainees on protective behavioral and social factors related to Alzheimer's disease and related dementias...
- This federal Project Grant award for $2,557,260 from the National Institute on Aging (CFDA 93.866 Aging Research program) will fund a study titled "Lifecourse Predictors and Mechanisms of Early Clinical ADRD among Black and White Adults in their Sixties". The study aims to investigate the transition from midlife to early late-life and identify the earliest manifestations of Alzheimer's disease (AD) and Alzheimer's disease-related disorders (ADRD) in a diverse population. The research...